Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1993 2
1999 1
2000 1
2007 1
2008 3
2009 4
2010 4
2011 1
2012 9
2013 7
2014 9
2015 2
2016 7
2017 9
2018 6
2019 8
2020 3
2021 3
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Phenotypes of Atopic Dermatitis Depending on the Timing of Onset and Progression in Childhood.
Roduit C, Frei R, Depner M, Karvonen AM, Renz H, Braun-Fahrländer C, Schmausser-Hechfellner E, Pekkanen J, Riedler J, Dalphin JC, von Mutius E, Lauener RP; the PASTURE study group; Hyvärinen A, Kirjavainen P, Remes S, Roponen M, Dalphin ML, Kaulek V, Ege M, Genuneit J, Illi S, Kabesch M, Schaub B, Pfefferle PI, Doekes G. Roduit C, et al. Among authors: dalphin ml. JAMA Pediatr. 2017 Jul 1;171(7):655-662. doi: 10.1001/jamapediatrics.2017.0556. JAMA Pediatr. 2017. PMID: 28531273 Free PMC article.
[Hypersensitivity pneumonitis in children].
Soumagne T, Dalphin ML, Dalphin JC. Soumagne T, et al. Among authors: dalphin ml. Rev Mal Respir. 2019 Apr;36(4):495-507. doi: 10.1016/j.rmr.2018.06.010. Epub 2019 Apr 19. Rev Mal Respir. 2019. PMID: 31010760 Review. French.
Can we decondition TRIKAFTA® tablets for the younger ones?
Gabsi A, Benaboud S, Pouradier D, Reix P, L'Excellent S, Weiss L, Le-Clainche L, Dalphin ML, Perisson C, Deneuville E, Bonnel AS, Sermet-Gaudelus I; CF Pediatric French Network for Cystic Fibrosis. Gabsi A, et al. Among authors: dalphin ml. J Cyst Fibros. 2023 Oct 25:S1569-1993(23)00929-3. doi: 10.1016/j.jcf.2023.10.006. Online ahead of print. J Cyst Fibros. 2023. PMID: 37891070 No abstract available.
Trajectories of cough without a cold in early childhood and associations with atopic diseases.
Divaret-Chauveau A, Mauny F, Hose A, Depner M, Dalphin ML, Kaulek V, Barnig C, Schaub B, Schmausser-Hechfellner E, Renz H, Riedler J, Pekkanen J, Karvonen AM, Täubel M, Lauener R, Roduit C, Vuitton DA, von Mutius E, Demoulin-Alexikova S; PASTURE study group. Divaret-Chauveau A, et al. Among authors: dalphin ml. Clin Exp Allergy. 2023 Apr;53(4):429-442. doi: 10.1111/cea.14257. Epub 2022 Dec 1. Clin Exp Allergy. 2023. PMID: 36453463
[Choanal atresia and CHARGE syndrome].
Dalphin ML, Noir A, Menget A. Dalphin ML, et al. Pediatrie. 1993;48(7-8):537-42. Pediatrie. 1993. PMID: 8165113 Review. French.
First Wave of COVID-19 in French Patients with Cystic Fibrosis.
Corvol H, de Miranda S, Lemonnier L, Kemgang A, Reynaud Gaubert M, Chiron R, Dalphin ML, Durieu I, Dubus JC, Houdouin V, Prevotat A, Ramel S, Revillion M, Weiss L, Guillot L, Boelle PY, Burgel PR. Corvol H, et al. Among authors: dalphin ml. J Clin Med. 2020 Nov 10;9(11):3624. doi: 10.3390/jcm9113624. J Clin Med. 2020. PMID: 33182847 Free PMC article.
Health-related quality of life in infants and children with interstitial lung disease.
Lauby C, Boelle PY, Abou Taam R, Bessaci K, Brouard J, Dalphin ML, Delacourt C, Delestrain C, Deschildre A, Dubus JC, Fayon M, Giovannini-Chami L, Houdouin V, Houzel A, Marguet C, Pin I, Reix P, Renoux MC, Schweitzer C, Tatopoulos A, Thumerelle C, Troussier F, Wanin S, Weiss L, Clement A, Epaud R, Nathan N. Lauby C, et al. Among authors: dalphin ml. Pediatr Pulmonol. 2019 Jun;54(6):828-836. doi: 10.1002/ppul.24308. Epub 2019 Mar 13. Pediatr Pulmonol. 2019. PMID: 30868755
The global impact of SARS-CoV-2 in 181 people with cystic fibrosis.
McClenaghan E, Cosgriff R, Brownlee K, Ahern S, Burgel PR, Byrnes CA, Colombo C, Corvol H, Cheng SY, Daneau G, Elbert A, Faro A, Goss CH, Gulmans V, Gutierrez H, de Monestrol I, Jung A, Justus LN, Kashirskaya N, Marshall BC, McKone E, Middleton PG, Mondejar-Lopez P, Pastor-Vivero MD, Padoan R, Rizvi S, Ruseckaite R, Salvatore M, Stephenson AL, Filho LVRDS, Melo J, Zampoli M, Carr SB; Global Registry Harmonization Group. McClenaghan E, et al. J Cyst Fibros. 2020 Nov;19(6):868-871. doi: 10.1016/j.jcf.2020.10.003. Epub 2020 Nov 4. J Cyst Fibros. 2020. PMID: 33183965 Free PMC article.
Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis.
Burgel PR, Munck A, Durieu I, Chiron R, Mely L, Prevotat A, Murris-Espin M, Porzio M, Abely M, Reix P, Marguet C, Macey J, Sermet-Gaudelus I, Corvol H, Bui S, Lemonnier L, Dehillotte C, Da Silva J, Paillasseur JL, Hubert D; French Cystic Fibrosis Reference Network Study Group. Burgel PR, et al. Am J Respir Crit Care Med. 2020 Jan 15;201(2):188-197. doi: 10.1164/rccm.201906-1227OC. Am J Respir Crit Care Med. 2020. PMID: 31601120
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
Carr SB, McClenaghan E, Elbert A, Faro A, Cosgriff R, Abdrakhmanov O, Brownlee K, Burgel PR, Byrnes CA, Cheng SY, Colombo C, Corvol H, Daneau G, Goss CH, Gulmans V, Gutierrez H, Harutyunyan S, Helmick M, Jung A, Kashirskaya N, McKone E, Melo J, Middleton PG, Mondejar-Lopez P, de Monestrol I, Nährlich L, Padoan R, Parker M, Pastor-Vivero MD, Rizvi S, Ruseckaite R, Salvatore M, da Silva-Filho LVRF, Versmessen N, Zampoli M, Marshall BC, Stephenson AL; CF Registry Global Collaboration. Carr SB, et al. J Cyst Fibros. 2022 Jul;21(4):e221-e231. doi: 10.1016/j.jcf.2022.06.006. Epub 2022 Jun 13. J Cyst Fibros. 2022. PMID: 35753987 Free PMC article.
70 results